Gregory E. Bobyock

OTC And Generic Drugs

Gregory E. Bobyock is providing advice on OTC and Generic Drugs to FPG with respect to clinical, scientific, and commercial matters related to current and prospective clients.

Greg has over thirty years of experience in new product development, marketing and business development in the Rx and OTC fields.. Over the past 20 years, he has held leadership positions at major OTC and consumer packaged goods companies including Pfizer, GSK and Nestle (where he headed up the global business development function). Greg and his teams were responsible for [1] bringing OTC products to market including the Advil Liquigel while at Pfizer and [2] transforming businesses through strategic M&A transactions including the creation of the GSK and Novartis Consumer Healthcare JV. At Nestle, he organized the purchase of the Atrium business, which included Garden of Life, the #1 leading dietary supplement line in the health food channel and Zenpep, the #2 Rx pancreatic replacement therapy, from Allergan

Greg retired from Nestle in December 2020 but continues do Board and advisory work for it, such as representing Nestle on the Board of Before Brands, a West Coast start-up (infant foods for prevention of food allergies). Greg received his Bachelor of Arts in History and Modern European Languages from La Salle University in Philadelphia, PA.